Pancreatic Cancer Research

ResearcherBeckman Research InstituteActive in the last 2 years

Caiming Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7794-2301; OpenAlex author ID A5069379096. Sources: OpenAlex.

Their work

Papers
9 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 3 papers · 2025: 1 paper · 2026: 1 paper

Papers 9

  1. An Exosomal Signature for Preoperative Detection of Occult Liver Metastasis in Pancreatic Cancer. Co-author DOI 10.1001/jamasurg.2026.3840↗
  2. Laparoscopic radical antegrade modular pancreatosplenectomy vesus laparoscopic distal pancreatosplenectomy for left-sided pancreatic cancer: a systematic revie… Co-author DOI 10.3389/fonc.2025.1510342↗
  3. The LAMB3-EGFR signaling pathway mediates synergistic Anti-Cancer effects of berberine and emodin in Pancreatic cancer. Co-author DOI 10.1016/j.bcp.2024.116509↗
  4. A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2023.09.050↗
  5. Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic Cancer. First author DOI 10.3390/ph17070911↗
  6. Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/biomedicines11010119↗
  7. Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/ph15101199↗
  8. Application of Mass Spectrometry in Pancreatic Cancer Translational Research. Co-author DOI 10.3389/fonc.2021.667427↗
  9. The landscape of immune cell infiltration and its clinical implications of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.jare.2020.03.009↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ajay Goel · 6 shared papers, 2022–2026 · strength 1.38
  2. Cristina Fillat · 4 shared papers, 2022–2024 · strength 0.92
  3. Silvia Pascual-Sabater · 4 shared papers, 2022–2024 · strength 0.92
  4. Guixin Zhang · 4 shared papers, 2020–2025 · strength 0.72
  5. Haiyong Han · 3 shared papers, 2022–2024 · strength 0.61
  6. Song Cheol Kim · 2 shared papers, 2024–2026 · strength 0.46
  7. Daniel D. Von Hoff · 2 shared papers, 2024–2026 · strength 0.46
  8. Keisuke Okuno · 2 shared papers, 2022–2023 · strength 0.35
  9. Xutao Jiang · 1 shared paper, 2025 · strength 0.28
  10. Wei Li · 1 shared paper, 2025 · strength 0.28
  11. Jingyang Yin · 1 shared paper, 2026 · strength 0.26
  12. Mitsuro Kanda · 1 shared paper, 2026 · strength 0.26
  13. Mitsuo Shimada · 1 shared paper, 2026 · strength 0.26
  14. Takayuki Noma · 1 shared paper, 2026 · strength 0.26
  15. Vincent M. Chung · 1 shared paper, 2026 · strength 0.26
  16. Yuan Li · 1 shared paper, 2024 · strength 0.26
  17. Hailong Chen · 2 shared papers, 2020–2021 · strength 0.24
  18. John S. Bolton · 1 shared paper, 2024 · strength 0.20
  19. Eunsung Jun · 1 shared paper, 2024 · strength 0.20
  20. Dong Shang · 1 shared paper, 2024 · strength 0.20
  21. Akinobu Taketomi · 1 shared paper, 2024 · strength 0.20
  22. Erkut Hasan Borazanci · 1 shared paper, 2024 · strength 0.20
  23. Tetsuji Takayama · 1 shared paper, 2023 · strength 0.18
  24. Peng Ge · 1 shared paper, 2021 · strength 0.13
  25. Yalan Luo · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.